These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 19473104

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Drug treatment of depression in the 2000s: An overview of achievements in the last 10 years and future possibilities.
    Baghai TC, Volz HP, Möller HJ.
    World J Biol Psychiatry; 2006; 7(4):198-222. PubMed ID: 17071541
    [Abstract] [Full Text] [Related]

  • 7. Treatment of mood disorders.
    Nemeroff CB, Owens MJ.
    Nat Neurosci; 2002 Nov; 5 Suppl():1068-70. PubMed ID: 12403988
    [Abstract] [Full Text] [Related]

  • 8. Neuropharmacological basis of combining antidepressants.
    de la Gándara J, Rojo JE, Ros S, Agüera L, de Pedro JM.
    Acta Psychiatr Scand Suppl; 2005 Nov; (428):11-3, 36. PubMed ID: 16307615
    [Abstract] [Full Text] [Related]

  • 9. Are two antidepressant mechanisms better than one? Issues in clinical trial design and analysis.
    Leon AC.
    J Clin Psychiatry; 2004 Nov; 65 Suppl 4():31-6. PubMed ID: 15046539
    [Abstract] [Full Text] [Related]

  • 10. 5-HT7 receptor antagonists as a new class of antidepressants.
    Mnie-Filali O, Lambás-Señas L, Zimmer L, Haddjeri N.
    Drug News Perspect; 2007 Dec; 20(10):613-8. PubMed ID: 18301795
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Emerging drugs for major depressive disorder.
    Kennedy SH, Rizvi SJ.
    Expert Opin Emerg Drugs; 2009 Sep; 14(3):439-53. PubMed ID: 19637989
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. How antidepressants help depression: mechanisms of action and clinical response.
    Delgado PL.
    J Clin Psychiatry; 2004 Sep; 65 Suppl 4():25-30. PubMed ID: 15046538
    [Abstract] [Full Text] [Related]

  • 15. Interest of using genetically manipulated mice as models of depression to evaluate antidepressant drugs activity: a review.
    Gardier AM, Guiard BP, Guilloux JP, Repérant C, Coudoré F, David DJ.
    Fundam Clin Pharmacol; 2009 Feb; 23(1):23-42. PubMed ID: 19267769
    [Abstract] [Full Text] [Related]

  • 16. Antidepressants and brain monoaminergic systems: a dimensional approach to understanding their behavioural effects in depression and anxiety disorders.
    Morilak DA, Frazer A.
    Int J Neuropsychopharmacol; 2004 Jun; 7(2):193-218. PubMed ID: 15003145
    [Abstract] [Full Text] [Related]

  • 17. New drug targets in the signaling pathways activated by antidepressants.
    Páez-Pereda M.
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jul; 29(6):1010-6. PubMed ID: 15946780
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [The serotonin concept of depression in light of the mechanism of action of antidepressant drugs].
    Kostowski W, Płaźnik A.
    Psychiatr Pol; 1989 Jul; 23(2):117-24. PubMed ID: 2682712
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.